Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 3,550,000 | 3,400,000 | 3,147,000 | 2,848,000 | 2,842,000 |
| Cost of Goods | 1,622,000 | 1,631,000 | 1,576,000 | 1,249,000 | 1,350,000 |
| Gross Profit | 1,928,000 | 1,769,000 | 1,571,000 | 1,599,000 | 1,492,000 |
| Operating Expenses | 1,078,000 | 1,015,000 | 1,019,000 | 895,000 | 842,000 |
| Operating Income | 850,000 | 754,000 | 552,000 | 704,000 | 650,000 |
| Other Income | -149,000 | -113,000 | -77,000 | -1,412,000 | 35,000 |
| Pre-tax Income | 701,000 | 641,000 | 475,000 | -708,000 | 685,000 |
| Income Tax | 49,000 | 98,000 | 25,000 | -23,000 | 47,000 |
| Net Income Continuous | 649,000 | 521,000 | 451,000 | -688,000 | 637,000 |
| Net Income | $649,000 | $521,000 | $451,000 | $-688,000 | $637,000 |
| EPS Basic Total Ops | 0.73 | 0.61 | 0.53 | -0.88 | 0.81 |
| EPS Basic Continuous Ops | 0.73 | 0.61 | 0.53 | -0.88 | 0.81 |
| EPS Diluted Total Ops | 0.72 | 0.58 | 0.51 | -0.88 | 0.77 |
| EPS Diluted Continuous Ops | 0.71 | 0.58 | 0.50 | -0.88 | 0.76 |
| EBITDA(a) | $1,104,000 | $1,011,000 | $709,000 | $822,000 | $777,000 |